What’s new in Flare™ V12: significant enhancements to FEP and structure-based methods

SHARE
16 July
Online
45 minutes
2pm BST | 3pm CET | 9am EST

Registrations are now closed – request webinar recording

Join our expert-led webinar to explore powerful new capabilities delivering faster, more accurate binding predictions across complex drug discovery challenges.

We are excited to announce the release of Flare V12, introducing a range of new capabilities, improving the efficiency, accuracy, and scope of computational drug discovery workflows. Flare V12 sees significant developments to Cresset’s Flare FEP offering, now including replica exchange, Grand Canonical Monte Carlo (GCMC) water sampling and the ability to model more complex molecular changes such as ring-breaking transformations and scaffold hopping. Alongside the specific FEP developments, Flare V12 will support molecular dynamics (MD) simulations for covalent ligands and non-standard amino acid residues. Such improvements have been designed to help researchers generate reliable binding predictions more efficiently and to support decision-making across a wider range of drug discovery challenges. Join us in this webinar to learn more about the advancements Cresset has made for Flare V12, exploring worked examples.

• Generate more reliable FEP predictions faster
• Model more complex systems with ease
• Reduce manual setup and streamline workflows
• Make better-informed decisions across your pipeline

Lauren Nelson

Senior Solutions Scientist

Subscribe & Don't Miss Out

Receive our newsletter to be among the first to hear about product releases, case studies, opinion articles, events and more.